[8-K] StableX Technologies, Inc. Reports Material Event

Rhea-AI Filing Summary

StableX Technologies, Inc. disclosed new equity awards for leadership. On October 31, 2025, the Board granted stock options covering 311,405 shares to its CEO and non‑employee directors under the company’s Long‑Term Incentive Plan.

CEO Joshua Silverman received options for 220,513 shares, and each non‑employee director — Sebastian Giordano, Zvi Joseph, Greg Schiffman, and Wayne Walker — received options for 22,723 shares. The exercise price equals the greater of $6.25 per share or the fair market value on the grant date. The options have a 10‑year term.

The vesting schedule provides that 75% of each grant vested on the grant date and the remaining 25% vests on December 31, 2025, in each case contingent on continued service. The company’s common stock trades on Nasdaq under the symbol SBLX.

Insights

Executive compensation analyst

Routine option grants totaling 311,405 shares with time-based vesting.

StableX approved option awards covering 311,405 shares: the CEO received 220,513, and each of four directors 22,723. The strike price is the greater of $6.25 or fair market value on October 31, 2025, aligning awards with market pricing on the grant date. Options carry a 10-year term, a standard horizon for long-term incentives.

Vesting is time-based: 75% vested immediately on grant, with the remaining 25% vesting on December 31, 2025, conditioned on continued service. This structure emphasizes retention through year-end while delivering most value upfront.

As a routine compensation action disclosed under Item 5.02, there is no direct cash flow effect stated. The impact on shareholders depends on future stock performance and whether options are exercised, which occurs only if market price exceeds the strike.

false 0001086745 0001086745 2025-10-31 2025-10-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report

(Date of earliest event reported):

October 31, 2025

StableX Technologies, Inc.

(Exact name of registrant as specified in its charter)

Delaware		001-34643		98-0204758
(State or other jurisdiction of		(Commission		(IRS Employer
incorporation)		File No.)		Identification No.)

1185 Avenue of the Americas

New York, NY 10036

(Address of principal executive offices and zip code)

512-994-4917

(Registrant’s telephone number, including area code)

AYRO, Inc.

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common stock, par value $0.0001 per share		SBLX		The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

On October 31, 2025 (the “Grant Date”), the Board of Directors (the “Board”) of StableX Technologies, Inc. (the “Company”), based on the recommendation of the Compensation and Human Resources Committee of the Board, approved a grant to each of Joshua Silverman, the Company’s Chief Executive Officer, and each non-employee director of the Company, including Sebastian Giordano, Zvi Joseph, Greg Schiffman and Wayne Walker (collectively, the “Grantees”), stock options (“Options”) to purchase an aggregate of 311,405 shares of common stock, par value $0.0001 per share (“Common Stock”), of the Company consisting of: (i) Options to purchase up to 220,513 shares of Common Stock to Mr. Silverman and (ii) Options to purchase up to 22,723 shares of Common Stock to each non-employee director of the Company, with such Options having an exercise price equal to the greater of (i) $6.25 per share or (ii) the fair market value (as defined in the StableX Technologies, Inc. Long-Term Incentive Plan (the “Plan”)) per share on the Grant Date. The Options have a term of ten years and vest as follows: 75% of each of the respective Options vested on the Grant Date and 25% of each of the respective Options will vest on December 31, 2025, provided that in each case, the applicable Grantee is employed by or providing services to the Company through the applicable vesting date. The Options were granted pursuant to the Plan.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: October 31, 2025	StableX Technologies, Inc.
	By:	/s/ Joshua Silverman
	Name:	Joshua Silverman
	Title:	Chief Executive Officer

FAQ

What did StableX (SBLX) announce in this 8-K?

The company granted stock options for 311,405 shares to its CEO and non-employee directors under its Long-Term Incentive Plan.

How many options did StableX's CEO receive?

CEO Joshua Silverman received options to purchase 220,513 shares of common stock.

How many options did each StableX director receive?

Each non-employee director received options to purchase 22,723 shares.

What is the exercise price for the new StableX options?

The exercise price equals the greater of $6.25 per share or the fair market value on the grant date.

What is the vesting schedule for StableX’s option grants?

75% vested on October 31, 2025, with the remaining 25% vesting on December 31, 2025, subject to continued service.

What is the term of the StableX options?

The options have a 10-year term from the grant date.

Under which plan were the options granted?

They were granted pursuant to the StableX Technologies, Inc. Long-Term Incentive Plan.